Hannah M Knochelmann

8PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 05, 2025
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy.

Megen C Wittling, Amalia M Rivera-Reyes, Megan M Wyatt

|Jun 30, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Megen C Wittling, Hannah M Knochelmann, Megan M Wyatt

|Jan 08, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Megen C Wittling, Hannah M Knochelmann, Megan M Wyatt

|Oct 06, 2023
Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity.

Guillermo O Rangel Rivera, Connor J Dwyer, Hannah M Knochelmann

|Mar 22, 2023
The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner.

Guillermo O Rangel Rivera, Connor J Dwyer, Hannah M Knochelmann

|Aug 19, 2021
Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies.

Hannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt

Pageof 2